Previous 10 | Next 10 |
Summary Inogen has been a long-term growth story which has seen real execution challenges in recent years. Current supply chain woes make up for a tough margin picture, yet operational issues have been seen for a couple of years now. Valuations are not too demanding, not in th...
Summary Inogen came in with a mixed set of numbers, however, longer-term structural headwinds remain in situ. The hold rating on INGN remains intact following Q2 earnings, and I've noticed similar themed risks looking ahead. Chief to the downside risk is a further slowdown in ...
Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. In the second quarter, the Baron Discovery Fund was down 22.66% (Institutional Shares), which was 3.41% below the Russell...
Inogen, Inc. (INGN) Q2 2022 Earnings Conference Call August 04, 2022, 05:00 PM ET Company Participants Agnes Lee - SVP of IR and Strategic Planning Nabil Shabshab - President and CEO Kristin Caltrider - CFO Conference Call Participants Brett Fishbin -...
Inogen press release ( NASDAQ: INGN ): Q2 Non-GAAP EPS of -$0.02 beats by $0.31 . Revenue of $103.38M (+1.8% Y/Y) beats by $2.74M . For further details see: Inogen Non-GAAP EPS of -$0.02 beats by $0.31, revenue of $103.38M beats by $2.74M
Robust Sequential Revenue Growth Driven by Fulfilled Demand Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the quarter ended June 30, 2022 and provi...
Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release second quarter 2022 financial results after market close on Thursday, August 4, 2022. The Company will host a corre...
Inogen lacks the economic pillars to outplay macro-economic and industry-specific headwinds plaguing its share price. Supply shortages have destructed output and clamped down on margins, whilst COGS continues to spike. The company has expanded its rep count, reducing the target re...
Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Agnes Lee to the position of Senior Vice President of Investor Relations and Strategic Planning, effective May 23, 2022....
Inogen, Inc. (INGN) Q1 2022 Earnings Conference Call May 5, 2022, 5:00 pm ET Company Participants Jason Somer - General Counsel Nabil Shabshab - President & CEO Kristin Caltrider - CFO Conference Call Participants Lilia-Celine Lozada - J.P. Morgan Matthew Mishan - KeyBanc Capital Markets ...
News, Short Squeeze, Breakout and More Instantly...
Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report second quarter 2024 financial results after the market closes on Tuesday, August 6, 2024. On the same day, the Company wil...
Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Kevin P. Smith as General Counsel and Executive Vice President, Business Development, effective July 22, 2024. Mr. Smith jo...